NFKB1 and cholangiocarcinoma: The present study reports for the first time that all CCA tissues overexpressed NF-κB and suppression of NF-κB action by a specific NF-κB inhibitor, DHMEQ significantly suppressed growth and induced apoptosis in CCA cell lines, in CCA inoculated mice and in primary histocultures of CCA patient tissues.